Kastritis, E. Et Al. 2024. VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG). Clinical Lymphoma, Myeloma and Leukemia .

Kastritis, E., BEKSAÇ, M., Badelita, S. N., Katodritou, E., Bila, J., Spanoudakis, E., ... CENGİZ SEVAL, G.(2024). VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG). Clinical Lymphoma, Myeloma and Leukemia .

Kastritis, Efstathios Et Al. "VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)," Clinical Lymphoma, Myeloma and Leukemia , 2024

Kastritis, Efstathios Et Al. "VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)." Clinical Lymphoma, Myeloma and Leukemia , 2024

Kastritis, E. Et Al. (2024) . "VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)." Clinical Lymphoma, Myeloma and Leukemia .

@article{article, author={Efstathios Kastritis Et Al. }, title={VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)}, journal={Clinical Lymphoma, Myeloma and Leukemia}, year=2024}